Clinical Trial Update: A Study to Determine the Safety of Epoetin Alfa and Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients After Major Orthopedic Surgery. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety of epoetin alfa and whether it can reduce the need for blood transfusions after major orthopedic surgery. The study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Epogen (epoetin alfa)
• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Blood Transfusion, Orthopedic Procedures | Phase 2 | Status: COMPLETED